Events conducted in Zurich and Monaco at upscale hotels and spas prime locations for SolaJet installations
Europe represents a large market for advanced health and wellness technologies
DENVER, July 02, 2021 (GLOBE NEWSWIRE) — Omnia Wellness Inc. (the “Company”) (Nasdaq: OMWS), a health and wellness company commercializing advanced therapeutic technologies, today announced that it will host a series of events in Monaco and Switzerland with executives in the health and wellness industry, to discuss opportunities to commercialize its SolaJet Dry-Hydrotherapy System and other products throughout the U.S. and international markets.
“We’re very excited to demonstrate the value and benefits of our SolaJet Dry-Hydrotherapy System to leading executives in the European health and wellness markets as well as to those in the hotel and resort industries,” said Omnia Wellness Executive Chairman Steve Howe. “There’s a very high level of interest in the European Union countries — our event in Zurich is drawing exceptional interest, and our event in Monte Carlo was over-subscribed, so we had to book a larger facility — whose population of nearly 450 million people is very receptive to new ways to improve health and wellness. We’ll be talking about bringing our brand to clientele in Switzerland as well as in Monaco, the Italian and French Rivieras, and across Western and Central Europe.”
The patented SolaJet Dry-Hydrotherapy System delivers a proprietary Endo-kinetic therapy that utilizes water to fuse four treatments in one modality — deep tissue penetration, sequential compression, vibration and penetrating heat. Sessions can remarkably rejuvenate the body in as little as 15 minutes, surpassing many of the benefits of a traditional 1-hour massage. In addition, the SolaJet addresses the concerns of an estimated 40 percent of the U.S. population (pre-Covid) who will not receive a massage because of their aversion to touch.
Where: Hotel La Tureta, Bellinzona, Switzerland
When: Thursday, 8 July 2021
Where: Fairmont Monte Carlo
When: Noon, Monday, 12 July 2021
McKinsey & Company analysts peg the wellness market alone at $1.5 trillion and expect that market to grow at a rate of 5 to 10 percent annually. The overall health and wellness market worldwide could reach more than three times that, or $4.65 trillion, in 2021, according to Wellness Creatives.
About Omnia Wellness Inc.
Omnia Wellness Inc. is an innovative developer of a disruptive dry-hydrotherapy technology for massage, fitness and medical applications in the Health and Wellness industry. Through its subsidiaries Omnia Wellness Inc. and Solajet Financing Company, Omnia Wellness expects to commercialize SolaJet’s Dry-Hydrotherapy, Endo-Kinetic technology, which provides deep tissue suppression penetration, vibration, therapeutic heat, and a flushing full-body “wave” combining 4 therapies in 1. Treatments are designed to deliver the feeling similar to an hour-long traditional massage in as little as 15 minutes at an affordable price point for the consumer. In response to Covid-19, the Company is emphasizing its technology as “touchless” therapy. It is the expectation of Omnia Wellness to create a national chain of “BodyStop® Relaxation and Therapeutic Centers,” with the first a beta BodyStop® expected to open in the third quarter of 2021, and “BodyStop® Recovery Zones,” which are expected to be made available at fitness clubs.
This press release may contain “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to: statements regarding the Company’s overall business; total addressable market; and expectations regarding future sales and expenses. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these as forward-looking statements. Moreover, forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to successfully implement training programs for the use of its products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to develop sales for its new product solutions; the acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense, and time associated with sales; the lengthy evaluation and sales cycle for the Company’s products; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the business impact of health crises or outbreaks of disease, such as epidemics or pandemics; the ability to obtain export licenses for countries outside the U.S.; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company’s ability to maintain and enhance its brand, as well as other risk factors. These forward-looking statements are made as of the date of this press release and are based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, or changes in its expectations.